Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs — especially those based on antibodies — more safely and efficiently.
Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases. They also used the sensors to monitor the structure of antibody molecules, including whether they contain a chain of sugars that interferes with proper function.
“This could help pharmaceutical companies figure out why certain drug formulations work better than others, and may help improve their effectiveness,” says Michael Strano, an MIT professor of chemical engineering and senior author of a recent paper describing the sensors in the journal ACS Nano.
The team also demonstrated how nanosensor arrays could be used to determine which cells in a population of genetically engineered, drug-producing cells are the most productive or desirable, Strano says.
Lead author of the paper is Nigel Reuel, a graduate student in Strano’s lab. The labs of MIT faculty members Krystyn Van Vliet, Christopher Love and Dane Wittrup also contributed, along with scientists from Novartis.
Testing drug strength
Strano and other scientists have previously shown that tiny, nanometer-sized sensors, such as carbon nanotubes, offer a powerful way to detect minute quantities of a substance. Carbon nanotubes are 50,000 times thinner than a human hair, and they can bind to proteins that recognize a specific target molecule. When the target is present, it alters the fluorescent signal produced by the nanotube in a way that scientists can detect.
Some researchers are trying to exploit large arrays of nanosensors, such as carbon nanotubes or semiconducting nanowires, each customized for a different target molecule, to detect many different targets at once. In the new study, Strano and his colleagues wanted to explore unique properties that emerge from large arrays of sensors that all detect the same thing.
The first feature they discovered, through mathematical modeling and experimentation, is that uniform arrays can measure the distribution in binding strength of complex proteins such as antibodies. Antibodies are naturally occurring molecules that play a key role in the body’s ability to recognize and defend against foreign invaders. In recent years, scientists have been developing antibodies to treat disease, particularly cancer. When those antibodies bind to proteins found on cancer cells, they stimulate the body’s own immune system to attack the tumor.
For antibody drugs to be effective, they must strongly bind their target. However, the manufacturing process, which relies on nonhuman, engineered cells, does not always generate consistent, uniformly binding batches of antibodies.
Currently, drug companies use time-consuming and expensive analytical processes to test each batch and make sure it meets the regulatory standards for effectiveness. However, the new MIT sensor could make this process much faster, allowing researchers to not only better monitor and control production, but also to fine-tune the manufacturing process to generate a more consistent product.
“You could use the technology to reject batches, but ideally you’d want to use it in your upstream process development to better define culture conditions, so then you wouldn’t produce spurious lots,” Reuel says.
Measuring weak interactions
Another useful trait of such sensors is their ability to measure very weak binding interactions, which could also help with antibody drug manufacturing.
The Latest Bing News on:
- Mastering the art of nanoscale construction to breathe easy and bust fraudon November 17, 2020 at 6:33 am
An innovative approach to nanoscale assembly has been successfully demonstrated, with the accuracy, scalability and control required to offer new tools for chemical sensing and anti-counterfeiting.
- Tattoos with microsensors could one day warn of health riskson November 13, 2020 at 9:00 pm
Imagine a tattoo that alerts you to a health problem signaled by a change in your biochemistry, or to radiation exposure that could be dangerous to your health,” Bruns wrote in an article on the ...
- Core/shell nanoparticles as efficient reducing agentson November 12, 2020 at 4:00 pm
As published in the journal Nanoscale ("Charge carrier pairing can impart efficient reduction efficiency to core/shell quantum dots: applications for chemical sensing"), CdZnS quantum dots were being ...
- Stretchable 'skin' sensor gives robots human sensationon November 12, 2020 at 2:52 pm
Cornell University researchers have created a fiber-optic sensor that combines low-cost LEDs and dyes, resulting in a stretchable ''skin'' that detects deformations such as pressure, bending and ...
- Stretchable 'skin' sensor gives robots human sensationon November 12, 2020 at 12:22 pm
This sensor could give soft robotic systems - and ... The researchers made use of the Cornell NanoScale Science and Technology Facility and Cornell Center for Materials Research, both of which ...
- Stretchable sensor gives robots and VR a human touchon November 12, 2020 at 12:08 pm
It's not a stretch to say that stretchable sensors could change the way soft robots function and feel. In fact, they will be able to feel quite ...
- What’s Next in Healthcare Products as a Result of COVID?on November 11, 2020 at 8:04 am
(B) Sensor under full extension for finger bending ... and creep due to the liquid-like nature of polymers at the nanoscale, which makes accurate, repeatable strain readouts an ongoing challenge.
- Nanosensors Market Forecast to 2027 – COVID-19 Impact and Regional Analysison November 11, 2020 at 1:31 am
The Global nanosensors Market is expected to exceed more than US$ 8.5 billion by 2024 and will grow at a CAGR of more than 80% in the given forecast period. Browse Full Report: The report covers ...
- Making complex 3D nanosuperconductors with DNA self-assemblyon November 10, 2020 at 2:14 am
For example, such 3-D superconducting nanostructures could find application in signal amplifiers to enhance the speed and accuracy of quantum computers and ultrasensitive magnetic field sensors for ..
- Tiny Smartphones Eyed for Next-Gen Microprocessorson November 9, 2020 at 4:00 pm
A team at Cornell University has developed the nanoscale sensors, which include an integrated circuit, solar cell, and light-emitting diodes (LEDs) all in a device of which 30,000 can fit on one side ...
The Latest Google Headlines on:
The Latest Bing News on:
- New Drug Delivery Systems Market 2020 – 2022 / Prediction by Leading Manufacturers, its Application and Typeson November 19, 2020 at 8:32 am
The New Drug Delivery Systems Market is anticipated to grow significantly over the forecast period 2020-2022 amid ...
- Implantable Drug Delivery Devices Market Size is Expected to Garner $13.21 Billion By 2027: AMRon November 19, 2020 at 7:32 am
According to the report published by Allied Market Research, the global Implantable Drug Delivery Devices Industry generated $10.09 billion in 2019, and is expected to garner $13.21 billion by 2027, ...
- First doses of scarce coronavirus drug administered to patients at Fort Worth hospitalon November 19, 2020 at 5:06 am
Limited amounts are being sent to hospitals, including Baylor Scott & White All Saints Medical Center, to treat mild and moderate COVID-19.
- Seelos Therapeutics Receives US Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosison November 19, 2020 at 4:45 am
PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for ...
- Biopharmaceutical Contract Manufacturing Asia Pacific Market to 2027 - by Product; Service and Geographyon November 19, 2020 at 4:23 am
The "Asia Pacific Biopharmaceutical Contract Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Service, and Geography" report has been added to ...
- Moderna Vaccine Production Is Gearing Up, Partner Lonza Sayson November 19, 2020 at 3:52 am
Lonza Group AG made its first commercial batch of the main ingredient in Moderna Inc.’s Covid-19 vaccine candidate in the U.S. last week and plans to start European production by the end of the month, ...
- UB-led study shows off-label drug extends insulin production for those with Type 1 diabeteson November 18, 2020 at 1:14 pm
A University at Buffalo pediatric endocrinologist's clinical trial found that an 11-year-old drug used to treat other autoimmune conditions can preserve insulin-making power for at least a year in som ...
- Westport drug manufacturing firm lays off 70on November 17, 2020 at 11:36 am
Drug manufacturer Meridian Medical Technologies said this month ... A Pfizer spokeswoman said in an email, "Due to decreased product demand at our Meridian St. Louis facility over the past several ...
- Drug Free Solution Inc. Readies for Major Product Launch Online for Holiday Seasonon November 17, 2020 at 5:15 am
Drug Free Solution Inc., (OTC: DSOL) The Board of Directors announced today that it is currently loading its Emotional Wellness product collection on the web site The product collection focuses on ...
- Warren wants answers on suspension of FDA inspections of overseas drug manufacturing facilitieson November 10, 2020 at 3:54 pm
In March, the Food and Drug Administration announced it would postpone on-site inspections. Right now, inspections are only happening on a case-by-case basis.